Navigation Links
Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
Date:9/2/2008

n track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. HGS also has three drugs in clinical development for the treatment of cancer, including two TRAIL receptor antibodies and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical development pipeline.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com This e-mail address is being protected from spam bots, you need JavaScript enabled to view it or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of new market ... 2013 Edition Material and Clinical Trial Requirements of ... Guidebook of Registration Application for Imported Traditional Chinese ... database. The traditional medicines in Orient, ... by occidental as mysterious medicines. Until today not ...
(Date:5/22/2013)... PRNewswire – iBio, Inc. (NYSE MKT: ... candidate for the newly emerged H7N9 influenza virus ... iBioLaunch™ platform. This validation milestone was achieved in ... information to purification of recombinant protein. ... The iBioLaunch platform eliminates the need to culture ...
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013 /PRNewswire/ ... in the development of novel therapeutics to target mechanisms of ... its investigational compounds, custirsen and OGX-427, will be presented as ... Meeting of the American Society of Clinical Oncology (ASCO) in ... June 4. Despite the availability of drugs ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5
(Date:5/22/2013)... 22, 2013 Hurricane preparation isn’t just ... That’s why Amica Insurance is reminding everyone ... upcoming hurricane season. , “An important part of hurricane ... a senior assistant vice president at Amica Insurance. “The ... the threat of a storm.” , Flood damage is ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Pamela ... received the Silicon Valley Business Journal’s 2013 Women of ... influence and dedication. , The reception took place ... Acknowledgement for Women of Influence is particularly humbling for ... each year. The greatest success is to recognize the ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- In the aftermath of ... only struggling to care for children and relatives, but also ... displaced during a natural disaster and relocating to temporary housing ... are offering a few tips on how to ease that ... yourself with your pet that can be used to help ...
(Date:5/22/2013)... May 22, 2013 Cedars-Sinai Heart Institute is ... leading pioneer in modern mitral heart valve repair, ... Eliot Corday, MD, International Prize in Heart Research. ... to recognize physicians and scientists conducting groundbreaking research, ... heart medicine. , Carpentier is a ...
(Date:5/22/2013)... Re-routing anti-cancer drugs to the "power plants" that make ... long-neglected approach to preventing emergence of the drug-resistant forms ... scientists are reporting. That,s the conclusion of a new ... . , Shana Kelley and colleagues explain that ... damaging the genes inside the nucleus of cancer cells. ...
Breaking Medicine News(10 mins):Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:Simple Steps Can Protect Pets in Weather Disasters 2Health News:Heart valve repair innovator receives Cedars-Sinai Heart Institute's Corday Prize in Heart Research 2
... Services, Inc. (NYSE: AHS ), the largest healthcare ... conference call to discuss fourth quarter and year end results ... The company expects to issue an earnings news release ... market at approximately 4:00 p.m. Eastern Time. A live webcast ...
... Homeland Security Chairman Bennie G. Thompson (D-MS) and ... Science and Technology, James R. Langevin (D-RI), released ... Ready for Pandemic Influenza." The report examines the ... the event of a pandemic influenza outbreak. It ...
... with Complex Rehab MarketHOUSTON, Jan. 14 Anne Kieschnik, ... experience, has joined Alliance Seating & Mobility ... rehab companies. Kieschnik is an Assistive Technology Professional ... Houston, Texas, for ASM ( www.alliance-seating.com ) and is ...
... effort focuses on genetics and who would benefit from ... research may one day help physicians identify those patients ... from certain treatments. , The discoveries, paving the way ... U.S. health-care system millions while sparing patients the agony ...
... Ken Thorpe and Alan Aviles, President and Chief ... and Hospitals Corporation, spoke to reporters today about ... in the economic stimulus package. President-elect Barack Obama ... investments necessary to ensure America,s medical records are ...
... Action for Children,s First Annual Awards CeremonyWASHINGTON, Jan. ... honored Senators Richard Lugar (R-IN), Christopher Dodd (D-CT), ... and Betty McCollum (D-MN-04) with the first annual ... award recognizes those who have done outstanding work ...
Cached Medicine News:Health News:AMN Healthcare Services to Host 2008 Fourth Quarter & Year End Earnings Conference Call on Thursday, February 26, 2009 2Health News:Report: Nation Not Ready for Pan Flu 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 3Health News:Researchers Zero In on GI Cancers 2Health News:Researchers Zero In on GI Cancers 3Health News:Researchers Zero In on GI Cancers 4Health News:PFCD Experts Cite Health Information Technology as Key Investment for Economic Stimulus 2Health News:Senators Lugar, Dodd, Boxer and Representatives Lee and McCollum Receive GAC Children's Champion Award 2
... Transfusion Safety Management system ensures your patients ... care. , BloodTrack SafeTx uses the AutoPPI™ ... from sample collection to transfusion. SafeTx checks ... reduces the need for bedside paperwork and ...
... Collections, a Cerner point-of-care solution, is ... and collection. The solution enhances the ... collections process by employing bar-code scanning ... system integration to prevent potential patient ...
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
... it comes to medication administration, any error ... make. The solution is the Dynamic Hospital ... bar-coded medication administration system, suitable for hospitals ... used stand-alone, networked, or as a fully-integrated ...
Medicine Products: